mRNA vaccines have several advantages that make them particularly valuable for controlling epidemics and pandemics. They can be developed and produced more rapidly than traditional vaccines, allowing for quicker responses to emerging infectious diseases. Additionally, mRNA vaccines can be easily adjusted to address new variants of a virus, which is critical in an evolving viral landscape.
